General Healthcare News
Researcher Christina Caira reflects on use of AI in Parkinson’s Disease research Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by the degeneration of dopamine releasing regions in the brain....
WHO’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countries Since the beginning of the pandemic, more than one million...
February 2, 2022 -- Artemis DNA’s two facilities, in Irvine, California and Houston, Texas, are now both CLIA and CAP accredited. Artemis DNA, Inc. (“Artemis DNA” or the “company”), a full-service, accredited, high...
Scientists have developed an artificial intelligence system that can analyse eye scans taken during a routine visit to an optician or eye clinic and identify patients at a high risk of a heart attack. Doctors have recognised that changes to...
PM and health minister reach agreement with drug company for ‘tens of thousands of doses’; initial data shows almost 90% efficacy Pfizer has pledged a shipment of its experimental antiviral COVID-19 pill to Israel, according to a Saturday...
A cheap and widely available drug used as an antidepressant now also appears to be a lifesaving covid-19 treatment. In a newly published, large-scale clinical trial, the drug fluvoxamine was shown to reduce the risk of prolonged...
